Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25-99
SponsorUniversity of Illinois at Chicago

About this trial

This study is being done to better understand how time restricted eating (eating all food in an 8 hour window) can help a person receiving chemotherapy treatment for breast cancer, stages I-IV. The aim is to find out if time restricted is feasible and acceptable to individuals starting chemotherapy for breast cancer. We will test 3 different eating window options compared to a control group for 24 weeks.

Eligibility criteria

Qualifiers

Age 25-99 at time of consent

English language or Spanish language (based on availability of lab interpreters)

ECOG 0 or 1

Breast cancer to meet histologically confirmed Stage I-III or Stage IV with Medical Oncology approval.

Disqualifiers

Women with type 1 or insulin dependent type 2 diabetes

Women with BMI > 45kg/m2 and < 18.5 kg/m2

Women who are pregnant or nursing. A negative serum or urine pregnancy test is required per institutional practice guidelines.

Shift workers

Trial design

Treatments tested in this trial

  • Time restricted eating

Treatment groups

40 Participants
are divided into 2 treatment groups